Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
118525153 | 11852515 | 3 | F | 20160903 | 20151218 | 20160903 | PER | US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-085459 | BRISTOL MYERS SQUIBB | 0.00 | F | Y | 0.00000 | 20160903 | MD | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
118525153 | 11852515 | 1 | PS | SPRYCEL | DASATINIB | 1 | Oral | 100 MG, QD | U | D583028B | 21986 | 100 | MG | FILM-COATED TABLET | QD |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
118525153 | 11852515 | 1 | White blood cell disorder |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
118525153 | 11852515 | Arthropathy | |
118525153 | 11852515 | Fatigue | |
118525153 | 11852515 | Gait disturbance | |
118525153 | 11852515 | Lethargy | |
118525153 | 11852515 | Osteoarthritis | |
118525153 | 11852515 | Product use issue | |
118525153 | 11852515 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
118525153 | 11852515 | 1 | 20151016 | 0 |